ImmuneSensor Therapeutics

About:

ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other diseases.

Website: https://www.immunesensor.com

Top Investors: Cancer Prevention and Research Institute of Texas

Description:

ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other autoimmune diseases. It is dedicated to developing new medicines that use the body's innate immune system to cure a variety of diseases. It was founded in 2019 and is based in Dallas, Texas, United States.

Total Funding Amount:

$26.1M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Dallas, Texas, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)immunesensor.com

Founders:

Qingsong Jet Li

Number of Employees:

1-10

Last Funding Date:

2022-12-05

IPO Status:

Private

Industries: